DBV Technologies reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Biocryst Pharmaceuticals BCRX:US USD 713.65M 91.47M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Galectin Therapeutics GALT:US USD 29.73M 230K
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Insmed INSM:US USD 807.82M 491K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
IONIS PHARMACEUT IONS:US USD 1.25B 1.34M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Ptc Therapeutics PTCT:US USD 1.06B 145.39M
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
United Therapeutics UTHR:US USD 800M 0
YTE INCY:US USD 33.59M 605K